NovaMechanics Ltd is an R&D performing SME committed to the computer aided design of new materials, small molecules and nanoparticles. NovaMechanics is focused in the development and implementation of in silico methods to guide decisions in the design and selection of promising candidates. Through the combination of industry-recognized expertise, state of the art software and proprietary computing infrastructure, the company’s advanced in silico capabilities in molecular design and simulation provide the most effective path to molecular innovation. NovaMechanics has a multidisciplinary experience in R&D projects (systems biology, drug discovery, nanoinformatics, health and environmental risk assessment, computational toxicology, property modelling & prediction etc).